The objective of the present investigation was to formulate and evaluate microencapsulated Glibenclamide produced by the emulsion–solvent evaporation method.
Methods
Microparticles were prepared using cellulose acetate by emulsion solvent evaporation method and characterized for their micromeritic properties, encapsulation efficiency, particle size, drug loading, FTIR, DSC, SEM analysis. In vitro release studies were performed in phosphate buffer (pH 7.4). Stability studies were conducted as per ICH guidelines.
Results
The resulting microparticles obtained by solvent evaporation method were free flowing in nature. The mean particle size of microparticles ranges from 132.54 to 178.44 μm and encapsulation efficiency ranges from 89.96 to 98.48%. The infrared spectra and differential scanning calorimetry thermographs confirmed the stable character of Glibenclamide in the drug-loaded microparticles. Scanning electron microscopy revealed that the microparticles were spherical in nature. In vitro release studies revealed that the drug release was sustained up to 12 h. The release kinetics of Glibenclamide from optimized formulation followed zero-order and peppas mechanism. The mechanism of drug release from the microparticles was found to be non-Fickian type.
Conclusion
Cellulose Acetate microparticles containing Glibenclamide could be prepared successfully by using an emulsion solvent evaporation technique, which will not only sustain the release of drug but also manage complicacy of the diabetes in a better manner.
{"title":"Characterization of Glibenclamide loaded cellulose acetate microparticles prepared by an emulsion solvent evaporation method","authors":"Sarath Chandiran Irisappan , Balagani Pavan Kumar , Korlakanti Narasimha Jayaveera","doi":"10.1016/j.jopr.2013.08.015","DOIUrl":"10.1016/j.jopr.2013.08.015","url":null,"abstract":"<div><h3>Aim</h3><p>The objective of the present investigation was to formulate and evaluate microencapsulated Glibenclamide produced by the emulsion–solvent evaporation method.</p></div><div><h3>Methods</h3><p>Microparticles were prepared using cellulose acetate by emulsion solvent evaporation method and characterized for their micromeritic properties, encapsulation efficiency, particle size, drug loading, FTIR, DSC, SEM analysis. In vitro release studies were performed in phosphate buffer (pH 7.4). Stability studies were conducted as per ICH guidelines.</p></div><div><h3>Results</h3><p>The resulting microparticles obtained by solvent evaporation method were free flowing in nature. The mean particle size of microparticles ranges from 132.54 to 178.44 μm and encapsulation efficiency ranges from 89.96 to 98.48%. The infrared spectra and differential scanning calorimetry thermographs confirmed the stable character of Glibenclamide in the drug-loaded microparticles. Scanning electron microscopy revealed that the microparticles were spherical in nature. In vitro release studies revealed that the drug release was sustained up to 12 h. The release kinetics of Glibenclamide from optimized formulation followed zero-order and peppas mechanism. The mechanism of drug release from the microparticles was found to be non-Fickian type.</p></div><div><h3>Conclusion</h3><p>Cellulose Acetate microparticles containing Glibenclamide could be prepared successfully by using an emulsion solvent evaporation technique, which will not only sustain the release of drug but also manage complicacy of the diabetes in a better manner.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 8","pages":"Pages 766-773"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.08.015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84117128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The aim of this work is to design & characterize a collagen based dermal films containing natural extracts such as Terminalia arjuna and Centella asiatica having antioxidant properties for enhancing the quality of wound healing.
Methods
The collagen and cross-linked collagen films were formulated with different concentrations of the selected extracts. The formulated films were subjected to physical, biochemical and histopathological examinations.
Results
Folding endurance reports revealed that the films possessed the desired mechanical strength to withstand the stress observed during handling. Micro shrinkage temperature of the extract impregnated films was found to be above 68 °C indicating their hydrothermal stability. Wound healing studies on male Wistar rats revealed that the groups treated with 1.5% T. arjuna extract impregnated cross-linked collagen dermal films (1.5% TAEICCDF's), 15% extract impregnated collagen dermal films (1.5% TAEICDF's), 1.5% C. asiatica extract impregnated cross-linked collagen dermal films (1.5% CAEICCDF's), 1.5% C. asiatica extract impregnated collagen dermal films (1.5% CAEICDF's) possessed higher amount of hydroxyproline content compared to the marketed formulation – Neuskin™. The cross-linking of the CAEICDF's, TAEICDF's had a significant impact at p > 0.05 from student ‘t’ test on wound healing compared to the non-cross-linked films. Further one-way classification ANOVA studies conducted for all the groups treated with natural extract impregnated films varied significantly (P = 0.05 from one-way ANOVA).
Conclusion
The histopathological studies indicated more production in the collagen content in groups treated with 1.5% TAEICCDF's, 1.5% TAEICDF's, 1.5% CAEICCDF's, 1.5% CAEICDF's which resulted in the epithelial group reduction. Further rise in fibroblasts in these treated groups suggested that the films are fit to productive approach in the improvement of dermal wound healing process.
{"title":"Design and characterization of natural extracts impregnated collagen based dermal films for wound healing","authors":"Medarametla Kishore Babu , Sabbarapu Mary Samyuktha , Talasila Eswara Gopala Krishna Murthy","doi":"10.1016/j.jopr.2013.08.027","DOIUrl":"10.1016/j.jopr.2013.08.027","url":null,"abstract":"<div><h3>Aim</h3><p>The aim of this work is to design & characterize a collagen based dermal films containing natural extracts such as <em>Terminalia arjuna</em> and <em>Centella asiatica</em> having antioxidant properties for enhancing the quality of wound healing.</p></div><div><h3>Methods</h3><p>The collagen and cross-linked collagen films were formulated with different concentrations of the selected extracts. The formulated films were subjected to physical, biochemical and histopathological examinations.</p></div><div><h3>Results</h3><p>Folding endurance reports revealed that the films possessed the desired mechanical strength to withstand the stress observed during handling. Micro shrinkage temperature of the extract impregnated films was found to be above 68 °C indicating their hydrothermal stability. Wound healing studies on male Wistar rats revealed that the groups treated with 1.5% <em>T. arjuna</em> extract impregnated cross-linked collagen dermal films (1.5% TAEICCDF's), 15% extract impregnated collagen dermal films (1.5% TAEICDF's), 1.5% <em>C. asiatica</em> extract impregnated cross-linked collagen dermal films (1.5% CAEICCDF's), 1.5% <em>C. asiatica</em> extract impregnated collagen dermal films (1.5% CAEICDF's) possessed higher amount of hydroxyproline content compared to the marketed formulation – Neuskin™. The cross-linking of the CAEICDF's, TAEICDF's had a significant impact at <em>p</em> > 0.05 from student ‘<em>t</em>’ test on wound healing compared to the non-cross-linked films. Further one-way classification ANOVA studies conducted for all the groups treated with natural extract impregnated films varied significantly (<em>P</em> = 0.05 from one-way ANOVA).</p></div><div><h3>Conclusion</h3><p>The histopathological studies indicated more production in the collagen content in groups treated with 1.5% TAEICCDF's, 1.5% TAEICDF's, 1.5% CAEICCDF's, 1.5% CAEICDF's which resulted in the epithelial group reduction. Further rise in fibroblasts in these treated groups suggested that the films are fit to productive approach in the improvement of dermal wound healing process.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 8","pages":"Pages 727-733"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.08.027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75505727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes mellitus is one of the most common endocrine disorders accompanied with many metabolic syndromes. Use of herbal medicines has always been an option to treat a great number of diseases such as diabetes and its complications. The aim of the present study is to investigate the liver protective effects of Syzygium cumini seed extract in alloxan induced diabetic Swiss albino mice.
Methods
Eighteen Swiss albino mice (weighing 28–32 g) were randomly divided into control, alloxan treated and S. cumini treated mice group. Diabetes was induced in mice by injecting intraperitoneally alloxan monohydrate at dose of 150 mg/kg body weight. Aqueous extracts of S. cumini seed at dose of 250 mg/kg body weight were given orally in diabetic mice daily for three weeks after established LD50 value.
Results
In diabetic mice, the SGOT, SGPT, Bilirubin and serum glucose levels were significantly increased in comparison with the control groups. Statistical analysis (p < 0.05) of the data indicated that aqueous extract of S. cumini were significantly decrease serum contents of liver enzymes (SGOT, SGPT and Bilirubin) as well as serum glucose in treated groups.
Conclusion
The results suggested that aqueous extracts of S. cumini seed possesses liver protective effect against alloxan induced diabetic mice.
{"title":"Liver protective effects of aqueous extract of Syzygium cumini in Swiss albino mice on alloxan induced diabetes mellitus","authors":"Bhaskar Sharma , Md. Sufiyan Siddiqui , Shiv Shanker Kumar , Gurudyal Ram , Manisha Chaudhary","doi":"10.1016/j.jopr.2013.07.020","DOIUrl":"10.1016/j.jopr.2013.07.020","url":null,"abstract":"<div><h3>Background</h3><p>Diabetes mellitus is one of the most common endocrine disorders accompanied with many metabolic syndromes. Use of herbal medicines has always been an option to treat a great number of diseases such as diabetes and its complications. The aim of the present study is to investigate the liver protective effects of <em>Syzygium cumini</em> seed extract in alloxan induced diabetic Swiss albino mice.</p></div><div><h3>Methods</h3><p>Eighteen Swiss albino mice (weighing 28–32 g) were randomly divided into control, alloxan treated and <em>S. cumini</em> treated mice group. Diabetes was induced in mice by injecting intraperitoneally alloxan monohydrate at dose of 150 mg/kg body weight. Aqueous extracts of <em>S. cumini</em> seed at dose of 250 mg/kg body weight were given orally in diabetic mice daily for three weeks after established LD<sub>50</sub> value.</p></div><div><h3>Results</h3><p>In diabetic mice, the SGOT, SGPT, Bilirubin and serum glucose levels were significantly increased in comparison with the control groups. Statistical analysis (<em>p</em> < 0.05) of the data indicated that aqueous extract of <em>S. cumini</em> were significantly decrease serum contents of liver enzymes (SGOT, SGPT and Bilirubin) as well as serum glucose in treated groups.</p></div><div><h3>Conclusion</h3><p>The results suggested that aqueous extracts of <em>S. cumini</em> seed possesses liver protective effect against alloxan induced diabetic mice.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"6 8","pages":"Pages 853-858"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.07.020","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76455873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The aim of this study is to isolate and structurally elucidate the flavone glycoside: 5,4-dihydroxy–3-(3-methyl-but-2-enyl) 3,5,6-trimethoxy-flavone-7-O-β-d-glucopyranoside from Feronia limonia L.
Methods
The air dried, powdered and defatted material of F. limonia L. fruits were extracted with rectified spirit extract was concentrated under reduced pressure to get a brown viscous mass, which was successively partitioned with petroleum ether, benzene, chloroform, ethyl acetate, acetone and methanol respectively. The ethyl acetate soluble part was concentrated under reduced pressure to get a brown syrupy mass, which when examined by TLC on silica-gel G using chloroform:methanol:water (8:5:3) and iodine vapors as visualizing agent displayed two spots. As such it was subjected to column chromatography on silica-gel Emerk and eluted by with acetone:methanol in various proportions. On removal of the solvent of fraction (7:4), light yellow needles (RS-2) were separated out. RS-2 was found to be homogenous on TLC (MeOH:H2O:ACOH, 4:6:1).
Results
RS-2 responded to all the following characteristic color reactions for flavonoids (Shibata test and reaction with 5% FeCl3) and also responded positively to Molisch test of glycoside; spectral analysis of the sample clearly showed the characteristic peaks of flavone glycoside as depicted in (Graph 1, Graph 2, Graph 3, Graph 4).
Conclusion
On the basis of spectral data obtained, the compound was identified as 5,4-dihydroxy–3-(3-methyl-but-2-enyl) 3,5,6-trimethoxy-flavone-7-O-β-d-glucopyranoside. Survey of the literature clearly indicated that 5,4-dihydroxy–3-(3-methyl-but-2-enyl) 3,5,6-trimethoxy-flavone-7-O-β-d-glucopyranoside, this is the first report from the fruit pulp of F. limonia L. a novel compound.
本研究的目的是分离和结构阐明黄酮类苷。方法采用整流精提取液对柠檬果进行风干、粉末状和脱脂提取,减压浓缩得到棕色粘性物质,分别用石油醚、苯、氯仿、乙酸乙酯、丙酮和甲醇对其进行分馏。乙酸乙酯可溶部分经减压浓缩得到棕色糖浆团,以氯仿:甲醇:水(8:5:3)和碘蒸气为显像剂,在硅胶G上进行薄层色谱检测,发现有两个斑点。在硅胶埃默克上进行柱层析,并用丙酮和甲醇按不同比例洗脱。除去分数(7:4)的溶剂,分离出淡黄色针状物(RS-2)。在TLC上发现RS-2是均匀的(MeOH:H2O:ACOH, 4:6:1)。结果rs -2对黄酮类化合物的显色反应(柴田试验和5% FeCl3反应)均有反应,对糖苷的Molisch试验也有反应;图1、图2、图3、图4清晰地显示了黄酮苷的特征峰。结论根据所得的光谱数据,鉴定该化合物为5,4-二羟基- 3-(3-甲基-2-烯基)3,5,6-三甲氧基黄酮-7- o -β-d-葡萄糖吡喃苷。查阅文献明确指出,5,4-二羟基- 3-(3-甲基-但-2-烯基)3,5,6-三甲氧基黄酮-7- o -β-d-葡萄糖吡喃苷,这是首次报道从柠檬果果肉中提取的一种新化合物。
{"title":"Isolation and structural elucidation of the novel flavone glycoside from Feronia limonia L.","authors":"Arshed Iqbal Dar , Gangaram Masar , Vikram Jadhaw , S.K. Bansal , R.C. Saxena","doi":"10.1016/j.jopr.2013.04.058","DOIUrl":"10.1016/j.jopr.2013.04.058","url":null,"abstract":"<div><h3>Background</h3><p>The aim of this study is to isolate and structurally elucidate the flavone glycoside: 5,4-dihydroxy–3-(3-methyl-but-2-enyl) 3,5,6-trimethoxy-flavone-7-<em>O</em>-β-<span>d</span>-glucopyranoside from <em>Feronia limonia</em> L.</p></div><div><h3>Methods</h3><p>The air dried, powdered and defatted material of <em>F. limonia</em> L. fruits were extracted with rectified spirit extract was concentrated under reduced pressure to get a brown viscous mass, which was successively partitioned with petroleum ether, benzene, chloroform, ethyl acetate, acetone and methanol respectively. The ethyl acetate soluble part was concentrated under reduced pressure to get a brown syrupy mass, which when examined by TLC on silica-gel G using chloroform:methanol:water (8:5:3) and iodine vapors as visualizing agent displayed two spots. As such it was subjected to column chromatography on silica-gel Emerk and eluted by with acetone:methanol in various proportions. On removal of the solvent of fraction (7:4), light yellow needles (RS-2) were separated out. RS-2 was found to be homogenous on TLC (MeOH:H<sub>2</sub>O:ACOH, 4:6:1).</p></div><div><h3>Results</h3><p>RS-2 responded to all the following characteristic color reactions for flavonoids (Shibata test and reaction with 5% FeCl<sub>3</sub>) and also responded positively to Molisch test of glycoside; spectral analysis of the sample clearly showed the characteristic peaks of flavone glycoside as depicted in (<span>Graph 1</span>, <span>Graph 2</span>, <span>Graph 3</span>, <span>Graph 4</span>).</p></div><div><h3>Conclusion</h3><p>On the basis of spectral data obtained, the compound was identified as 5,4-dihydroxy–3-(3-methyl-but-2-enyl) 3,5,6-trimethoxy-flavone-7-<em>O</em>-β-<span>d</span>-glucopyranoside. Survey of the literature clearly indicated that 5,4-dihydroxy–3-(3-methyl-but-2-enyl) 3,5,6-trimethoxy-flavone-7-<em>O</em>-β-<span>d</span>-glucopyranoside, this is the first report from the fruit pulp of <em>F. limonia</em> L. a novel compound.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 8","pages":"Pages 697-704"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.04.058","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81107764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-08-01DOI: 10.1016/j.jopr.2013.08.019
Rituparna Sarma, Ankit Verma, Hasnahana Chetia, Dhirendra K. Sharma
Aim
The objective of the investigation was to predict the three dimensional structure of ageing related proteins of Silurana tropicalis Gray 1864.
Methods
The protein sequences were collected from UniProt. Homology modeling of protein structures was generated in SWISS-MODEL workplace. The structures were assessed by ERRAT and RAMPAGE.
Results
In S. tropicalis Gray 1864, ageing related total 5 proteins sequences namely prohibitin-2 (301 aa), serum response factor-binding protein 1 (535 aa), reactive oxygen species modulator 1 (79 aa), CDGSH iron-sulfur domain-containing protein 2 (135 aa) and an uncharacterized protein (668 aa) were found (UniProt). SWISS-MODEL workspace generated reliable 3D structures of only two proteins prohibitin-2 (301 aa) and CDGSH iron-sulfur domain-containing protein 2 (135 aa), while it failed to give proper structures for other proteins due to lack of templates. In ERRAT assessment, prohibiin-2 and CDGSH iron-sulfur domain-containing protein 2 scored 51.82% and 97.48% respectively. While in RAMPAGE, prohibitin 2 and CDGSH iron-sulfur domain-containing protein 2 scored 90.7% and 97.7% respectively.
Conclusion
The present study demonstrated the 3D structures of prohibitin-2 and CDGSH iron-sulfur domain-containing protein 2.
{"title":"3D structure prediction of aging related proteins of Silurana tropicalis Gray, 1864","authors":"Rituparna Sarma, Ankit Verma, Hasnahana Chetia, Dhirendra K. Sharma","doi":"10.1016/j.jopr.2013.08.019","DOIUrl":"10.1016/j.jopr.2013.08.019","url":null,"abstract":"<div><h3>Aim</h3><p>The objective of the investigation was to predict the three dimensional structure of ageing related proteins of <em>Silurana tropicalis</em> Gray 1864.</p></div><div><h3>Methods</h3><p>The protein sequences were collected from UniProt. Homology modeling of protein structures was generated in SWISS-MODEL workplace. The structures were assessed by ERRAT and RAMPAGE.</p></div><div><h3>Results</h3><p>In <em>S. tropicalis</em> Gray 1864, ageing related total 5 proteins sequences namely prohibitin-2 (301 aa), serum response factor-binding protein 1 (535 aa), reactive oxygen species modulator 1 (79 aa), CDGSH iron-sulfur domain-containing protein 2 (135 aa) and an uncharacterized protein (668 aa) were found (UniProt). SWISS-MODEL workspace generated reliable 3D structures of only two proteins prohibitin-2 (301 aa) and CDGSH iron-sulfur domain-containing protein 2 (135 aa), while it failed to give proper structures for other proteins due to lack of templates. In ERRAT assessment, prohibiin-2 and CDGSH iron-sulfur domain-containing protein 2 scored 51.82% and 97.48% respectively. While in RAMPAGE, prohibitin 2 and CDGSH iron-sulfur domain-containing protein 2 scored 90.7% and 97.7% respectively.</p></div><div><h3>Conclusion</h3><p>The present study demonstrated the 3D structures of prohibitin-2 and CDGSH iron-sulfur domain-containing protein 2.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 8","pages":"Pages 762-765"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.08.019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89751001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-08-01DOI: 10.1016/j.jopr.2013.08.017
Marzina Ajrin, Newton Sen, Irfan Newaz Khan, Maria Islam Khan
Background
The present study explicates the effect of metals ion (Ca2+) on the in vitro availability of Amlodipine besylate owing to drug–metal interaction.
Methods
Spectral studies were performed in an aqueous system at a fixed temperature (37 ± 0.5)°C and under different pH by UV spectrophotometric method at various concentrations of drug and metal. A Job plot was used to determine the stoichiometry of a binding event and The Ardon's method confirmed the complexation. An in vitro study of protein binding of Amlodipine besylate and their 1:1 mixture with Ca2+ ion had been conducted by equilibrium dialysis method at (37 ± 0.5)°C and at pH 7.4 by using Bovine Serum Albumin (BSA).
Results
Spectral studies detected the initial complexation. By Job's plot it was found that the interaction of Amlodipine besylate with metal ion (Ca2+) form one complex with metal at composition of 1:1. The Ardon's spectrophotometric method confirmed the 1:1 complexation and the value of stability constant was higher at pH 7.4 (0.11). The percentage of protein binding of Amlodipine besylate with BSA was found to be 86% and 42% at high and low concentration range respectively. In presence of Ca2+ the percentage of protein binding of drug increased 46% at lower concentration range and 94% at higher concentration zone. The results were statistically significant (p < 0.05).
The Scatchard plots showed that in class I binding sites, the value of affinity constant and number of binding sites of 1:1 complexes with Ca2+ was 1.04 and 20.8 respectively.
Conclusion
Drug–metal complex might, therefore, decrease the free drug in plasma and tissue systems. This may change the pharmacokinetic properties of the drug and may affect the pharmacological effects. It is thus inferred that care and monitoring must be taken during combination therapy of Amlodipine besylate and Ca2+.
{"title":"Effect of Ca (II) ion on the in vitro availability and protein binding of Amlodipine besylate","authors":"Marzina Ajrin, Newton Sen, Irfan Newaz Khan, Maria Islam Khan","doi":"10.1016/j.jopr.2013.08.017","DOIUrl":"10.1016/j.jopr.2013.08.017","url":null,"abstract":"<div><h3>Background</h3><p>The present study explicates the effect of metals ion (Ca<sup>2+</sup>) on the <em>in vitro</em> availability of Amlodipine besylate owing to drug–metal interaction.</p></div><div><h3>Methods</h3><p>Spectral studies were performed in an aqueous system at a fixed temperature (37 ± 0.5)°C and under different pH by UV spectrophotometric method at various concentrations of drug and metal. A Job plot was used to determine the stoichiometry of a binding event and The Ardon's method confirmed the complexation. An <em>in vitro</em> study of protein binding of Amlodipine besylate and their 1:1 mixture with Ca<sup>2+</sup> ion had been conducted by equilibrium dialysis method at (37 ± 0.5)°C and at pH 7.4 by using Bovine Serum Albumin (BSA).</p></div><div><h3>Results</h3><p>Spectral studies detected the initial complexation. By Job's plot it was found that the interaction of Amlodipine besylate with metal ion (Ca<sup>2+</sup>) form one complex with metal at composition of 1:1. The Ardon's spectrophotometric method confirmed the 1:1 complexation and the value of stability constant was higher at pH 7.4 (0.11). The percentage of protein binding of Amlodipine besylate with BSA was found to be 86% and 42% at high and low concentration range respectively. In presence of Ca<sup>2+</sup> the percentage of protein binding of drug increased 46% at lower concentration range and 94% at higher concentration zone. The results were statistically significant (<em>p</em> < 0.05).</p><p>The Scatchard plots showed that in class I binding sites, the value of affinity constant and number of binding sites of 1:1 complexes with Ca<sup>2+</sup> was 1.04 and 20.8 respectively.</p></div><div><h3>Conclusion</h3><p>Drug–metal complex might, therefore, decrease the free drug in plasma and tissue systems. This may change the pharmacokinetic properties of the drug and may affect the pharmacological effects. It is thus inferred that care and monitoring must be taken during combination therapy of Amlodipine besylate and Ca<sup>2+</sup>.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 8","pages":"Pages 671-676"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.08.017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86773158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-08-01DOI: 10.1016/j.jopr.2013.08.006
Rajesha Shetty , Syed Shafi , Yuvaraja Kuberan
Novel 3,4,5-triarylisoxazole derivatives were synthesised by Suzuki reaction of 4-bromo-3, 5-diaryl isoxazoles with various boronic acid under microwave condition. The structures of the newly synthesised compounds are characterised by 1H NMR, 13C NMR, LC-MS and screened for their antifungal activity against Aspergillus flavus (NCIM No. 524), Fusarium oxysporum (NCIM No. 1072) and Candida albicans (NCIM No. 3102).
{"title":"Efficient synthesis of novel 3,4,5-triarylisoxazole derivatives and its antifungal activity studies","authors":"Rajesha Shetty , Syed Shafi , Yuvaraja Kuberan","doi":"10.1016/j.jopr.2013.08.006","DOIUrl":"10.1016/j.jopr.2013.08.006","url":null,"abstract":"<div><p>Novel 3,4,5-triarylisoxazole derivatives were synthesised by Suzuki reaction of 4-bromo-3, 5-diaryl isoxazoles with various boronic acid under microwave condition. The structures of the newly synthesised compounds are characterised by <sup>1</sup>H NMR, <sup>13</sup>C NMR, LC-MS and screened for their antifungal activity against <em>Aspergillus flavus</em> (NCIM No. 524), <em>Fusarium oxysporum</em> (NCIM No. 1072) and <em>Candida albicans</em> (NCIM No. 3102).</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"6 8","pages":"Pages 897-901"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.08.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81831510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The present study was aimed to evaluate phytochemical constituents and the safety of methanolic extract of root parts of Curculigo orchioides (MECO) by determining their potential toxicity after acute and 28-day repeated dose administration in Wistar Albino rats.
Methods
The phytochemical analysis was done by standard laboratory grade reagents. Acute and 28-day repeated dose oral toxicity studies were performed by the following OECD test guidelines 423 and 407 respectively.
Results
The present study reveals the presence of complex phytochemical constituents like flavonoids, saponins, glycosides, terpenoids, steroids and phenols. In acute toxicity study no treatment related death or toxic signs were observed with MECO administration. In repeated dose study no significant differences in body weight changes and hematology was observed between control and MECO groups. Conversely there was a decrease in serum glucose and cholesterol levels and an increase in protein levels in treated rats compared to control. No gross pathological findings and difference in relative organ weights were observed between control and treated rats. Histopathological examination revealed no abnormalities with the test drug treatment.
Conclusion
In conclusion C. orchioides was found to be non toxic in tested doses and experimental conditions.
{"title":"An investigation on preliminary phytochemical and safety profiles of methanolic root extract of Curculigo orchioides","authors":"Elumalai Anandakirouchenane , Irisappan Sarath Chandiran , Balamuthu Kadalmani","doi":"10.1016/j.jopr.2013.08.023","DOIUrl":"10.1016/j.jopr.2013.08.023","url":null,"abstract":"<div><h3>Objective</h3><p>The present study was aimed to evaluate phytochemical constituents and the safety of methanolic extract of root parts of <em>Curculigo orchioides</em> (MECO) by determining their potential toxicity after acute and 28-day repeated dose administration in Wistar Albino rats.</p></div><div><h3>Methods</h3><p>The phytochemical analysis was done by standard laboratory grade reagents. Acute and 28-day repeated dose oral toxicity studies were performed by the following OECD test guidelines 423 and 407 respectively.</p></div><div><h3>Results</h3><p>The present study reveals the presence of complex phytochemical constituents like flavonoids, saponins, glycosides, terpenoids, steroids and phenols. In acute toxicity study no treatment related death or toxic signs were observed with MECO administration. In repeated dose study no significant differences in body weight changes and hematology was observed between control and MECO groups. Conversely there was a decrease in serum glucose and cholesterol levels and an increase in protein levels in treated rats compared to control. No gross pathological findings and difference in relative organ weights were observed between control and treated rats. Histopathological examination revealed no abnormalities with the test drug treatment.</p></div><div><h3>Conclusion</h3><p>In conclusion <em>C. orchioides</em> was found to be non toxic in tested doses and experimental conditions.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 8","pages":"Pages 692-696"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.08.023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85741922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-08-01DOI: 10.1016/j.jopr.2013.08.018
Josephine Leno Jenita Joseph , Vijaya Chockalingam , Wilson Barnabas
Aim
Didanosine, a nucleoside reverse transcriptase inhibitor, is used to treat HIV infection in patients with or without acquired immunodeficiency syndrome. The objective of this study is to prepare didanosine loaded bovine serum albumin nanoparticles by desolvation technique and coated with 1% polysorbate 80 to improve antiretroviral therapy.
Method
Bovine serum albumin nanoparticles containing didanosine were prepared by desolvation technique and cross linked with 8% v/v glutaraldehyde solution. Ethanol and mannitol were used as a desolvating agent and cryoprotectant respectively. The formulated nanoparticles were characterized, evaluated and were subjected to stability studies over a period of three months. Biodistribution studies were investigated for the best formulation (D1).
Results
Nanoparticle size was averaged below 270 nm with 0.2 PDI and zeta potential was in the range of −23.0 to −36.6. Encapsulation efficiency ranges from 66 to 85.71% and % drug loading ranges from 9.48 to 28.34. Cumulative percent drug release was in range of 60–80% and release kinetics suggested that drug release was Fickian diffusion controlled. The stability studies over period of 3 months confirmed the stability of BSA nanoparticles. Biodistribution studies demonstrated that the drug level in macrophage organs can be enhanced by coating of nanoparticles with 1% polysorbate 80.
Conclusion
The method adopted is simple and able to prepare stable, spherical shaped nanoparticles which exhibit slow and sustained release.
{"title":"Development, characterization and evaluation of antiretroviral drug – Didanosine loaded serum albumin nanocarriers for an antiretroviral therapy","authors":"Josephine Leno Jenita Joseph , Vijaya Chockalingam , Wilson Barnabas","doi":"10.1016/j.jopr.2013.08.018","DOIUrl":"10.1016/j.jopr.2013.08.018","url":null,"abstract":"<div><h3>Aim</h3><p>Didanosine, a nucleoside reverse transcriptase inhibitor, is used to treat HIV infection in patients with or without acquired immunodeficiency syndrome. The objective of this study is to prepare didanosine loaded bovine serum albumin nanoparticles by desolvation technique and coated with 1% polysorbate 80 to improve antiretroviral therapy.</p></div><div><h3>Method</h3><p>Bovine serum albumin nanoparticles containing didanosine were prepared by desolvation technique and cross linked with 8% v/v glutaraldehyde solution. Ethanol and mannitol were used as a desolvating agent and cryoprotectant respectively. The formulated nanoparticles were characterized, evaluated and were subjected to stability studies over a period of three months. Biodistribution studies were investigated for the best formulation (D1).</p></div><div><h3>Results</h3><p>Nanoparticle size was averaged below 270 nm with 0.2 PDI and zeta potential was in the range of −23.0 to −36.6. Encapsulation efficiency ranges from 66 to 85.71% and % drug loading ranges from 9.48 to 28.34. Cumulative percent drug release was in range of 60–80% and release kinetics suggested that drug release was Fickian diffusion controlled. The stability studies over period of 3 months confirmed the stability of BSA nanoparticles. Biodistribution studies demonstrated that the drug level in macrophage organs can be enhanced by coating of nanoparticles with 1% polysorbate 80.</p></div><div><h3>Conclusion</h3><p>The method adopted is simple and able to prepare stable, spherical shaped nanoparticles which exhibit slow and sustained release.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 8","pages":"Pages 712-719"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.08.018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87156081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Plant-based foods provide, not only essential nutrients needed for life, but also other bioactive compounds for health promotion and disease prevention. Standardization is an essential measure of quality, purity and authenticity. The present study focuses on the investigation of physiochemical parameters and to identify and quantify Stigmasterol from the leaves of Dipteracanthus patulus (Jacq.) Nees.
Methods
Physiochemical analyses like total ash, acid insoluble ash, water soluble ash, moisture content (Loss on Drying) and extractive values were calculated by standard procedures. High performance liquid chromatography with photo diode array detector (HPLC-PDA) was used to quantify Stigmasterol in the methanolic leaves extract of D. patulus.
Results
The percentage of the total ash, acid insoluble ash, water soluble ash and moisture content (Loss on Drying) were 9.1%, 1.3%, 6.2% and 4.1% respectively. The methanolic extractive value was found to be higher (13.4%). HPLC analysis revealed that the methanolic leaves extract showed the presence of Stigmasterol and the content was 0.22 mg/g dry weight which supports the biological potency of the plant.
Conclusion
Physiochemical analyses have shown the purity and quality of crude drug. Quantitative estimation by HPLC-PDA revealed the presence of good percentage of stigmasterol in D. patulus. This study has grasped the importance since stigmasterol possesses lipid peroxidation inhibitory action and anticancer activity. These features make this plant a promising candidate for the further studies on isolation and pharmacological studies of this compound from D. patulus.
{"title":"Physiochemical analysis and HPLC-PDA method for quantification of stigmasterol in Dipteracanthus patulus (Jacq.) Nees","authors":"Kannikaparameswari Nachimuthu , Chinnaswamy Palaniswamy","doi":"10.1016/j.jopr.2013.08.014","DOIUrl":"10.1016/j.jopr.2013.08.014","url":null,"abstract":"<div><h3>Background</h3><p>Plant-based foods provide, not only essential nutrients needed for life, but also other bioactive compounds for health promotion and disease prevention. Standardization is an essential measure of quality, purity and authenticity. The present study focuses on the investigation of physiochemical parameters and to identify and quantify Stigmasterol from the leaves of <em>Dipteracanthus patulus</em> (Jacq.) Nees.</p></div><div><h3>Methods</h3><p>Physiochemical analyses like total ash, acid insoluble ash, water soluble ash, moisture content (Loss on Drying) and extractive values were calculated by standard procedures. High performance liquid chromatography with photo diode array detector (HPLC-PDA) was used to quantify Stigmasterol in the methanolic leaves extract of <em>D. patulus</em>.</p></div><div><h3>Results</h3><p>The percentage of the total ash, acid insoluble ash, water soluble ash and moisture content (Loss on Drying) were 9.1%, 1.3%, 6.2% and 4.1% respectively. The methanolic extractive value was found to be higher (13.4%). HPLC analysis revealed that the methanolic leaves extract showed the presence of Stigmasterol and the content was 0.22 mg/g dry weight which supports the biological potency of the plant.</p></div><div><h3>Conclusion</h3><p>Physiochemical analyses have shown the purity and quality of crude drug. Quantitative estimation by HPLC-PDA revealed the presence of good percentage of stigmasterol in <em>D. patulus</em>. This study has grasped the importance since stigmasterol possesses lipid peroxidation inhibitory action and anticancer activity. These features make this plant a promising candidate for the further studies on isolation and pharmacological studies of this compound from <em>D. patulus</em>.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 8","pages":"Pages 741-746"},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.08.014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88005972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}